RPG Life Sciences · NSE: RPGLIFE · BSE: 532983
Q2 FY19 results · Jul–Sep 2018
RPG Life Sciences reported revenue from operations of ₹90.50 crore and net profit of ₹2.16 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 90.50 | — | — | 79.89 | +13.3% |
| Other income | 0.06 | — | — | 0.39 | −84.6% |
| Total income | 90.56 | — | — | 80.28 | +12.8% |
| Profit before tax | 3.10 | — | — | 2.58 | +20.2% |
| Net profit for the period | 2.16 | — | — | 1.83 | +18.0% |
| EPS, basic (₹) | 1.31 | — | — | 1.11 | +18.0% |
| Net margin (%) | 2.4 | — | 2.3 |
Standalone
- Filed with BSE
- 10 Nov 2018, 14:39 IST
- Board meeting
- 05 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE